| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/06/2002 | CA2430080A1 Eukaryotic expression libraries based on double lox recombination and methods of use |
| 06/06/2002 | CA2430077A1 Modified arginine deiminase |
| 06/06/2002 | CA2430039A1 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 06/06/2002 | CA2429819A1 Cytokine-like proteins |
| 06/06/2002 | CA2429816A1 Sulfonated diarylrhodamine dyes as fluorescent labels |
| 06/06/2002 | CA2429814A1 Rna interference mediating small rna molecules |
| 06/06/2002 | CA2429749A1 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | CA2429723A1 Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | CA2429722A1 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | CA2429721A1 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | CA2429673A1 Bacteriophage composition useful in treating food products to prevent bacterial contamination |
| 06/06/2002 | CA2429599A1 Use of b7rp1 antagonists in ige-mediated disorders |
| 06/06/2002 | CA2429583A1 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 06/06/2002 | CA2429469A1 Human elongase genes and uses thereof |
| 06/06/2002 | CA2429272A1 Methods and compositions for the introduction of molecules into cells |
| 06/06/2002 | CA2427669A1 Devices and methods for biochip multiplexing |
| 06/06/2002 | CA2427472A1 Double and triple readout assay systems |
| 06/06/2002 | CA2425872A1 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 06/06/2002 | CA2402459A1 Method of producing a mouse suitable for engraftment, differentiation and proliferation of heterologous cells, mouse produced by this method and use of the mouse |
| 06/05/2002 | EP1211325A2 Apparatus and cartridge for detecting biopolymers |
| 06/05/2002 | EP1211324A2 Amplification and detection of organisms of the chlamydiaceae family |
| 06/05/2002 | EP1211320A2 Methods and compositions for synthesis of oligosacccharides using mutant glycosidase enzymes |
| 06/05/2002 | EP1211319A2 Gene transfer into pancreatic and biliary epithelial cells |
| 06/05/2002 | EP1211318A1 Paramyxoviruses comprising modified transcription start sequence |
| 06/05/2002 | EP1211317A1 Gene encoding protein participating in signal transduction of cytokinin |
| 06/05/2002 | EP1211316A1 Mutants of mycobacterium vaccae-derived formate dehydrogenase and uses thereof |
| 06/05/2002 | EP1211315A1 Recombinant vectors for producing HCV envelope proteins |
| 06/05/2002 | EP1211314A2 Expression of a human insulin precursor in p. pastoris |
| 06/05/2002 | EP1211313A2 Modulation of PDE11A activity |
| 06/05/2002 | EP1211312A2 Method for sterilizing transformed cells |
| 06/05/2002 | EP1211307A1 Method of piercing membrane and apparatus therefor |
| 06/05/2002 | EP1211260A1 Peptides from Ag85 of mycobacterium and uses thereof |
| 06/05/2002 | EP1210944A1 Blood plasma replacement solution |
| 06/05/2002 | EP1210875A1 Modulating gene expression in insects by using double-stranded RNA (dsRNA) |
| 06/05/2002 | EP1210874A1 Alpha-tocopherol transport protein knockout animal |
| 06/05/2002 | EP1210869A1 Construction of barley with decreased gel protein content |
| 06/05/2002 | EP1210603A2 Anti-epha2 antibodies as a cancer diagnostic |
| 06/05/2002 | EP1210590A1 Microfabricated injector and capillary array assembly for high-resolution and high throughput separations |
| 06/05/2002 | EP1210465A2 A method for producing quality assured biological sample and composition containing the same |
| 06/05/2002 | EP1210463A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 06/05/2002 | EP1210462A2 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications |
| 06/05/2002 | EP1210461A1 High sensitivity biomolecule detection with magnetic particles |
| 06/05/2002 | EP1210460A1 Gene cloning |
| 06/05/2002 | EP1210458A1 Arrays with mask layers and methods of manufacturing same |
| 06/05/2002 | EP1210457A2 Detection of differences in nucleic acids by inhibition of spontaneous dna branch migration |
| 06/05/2002 | EP1210455A1 Novel glycosyl sulfotransferases gst-4 alpha, gst-4 beta, and gst-6 |
| 06/05/2002 | EP1210454A1 Antisense modulation of shp-1 expression |
| 06/05/2002 | EP1210453A2 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 06/05/2002 | EP1210449A1 Methods for the detection, analysis and isolation of nascent proteins |
| 06/05/2002 | EP1210448A1 Recombinant hsv-1 and live viral vaccines |
| 06/05/2002 | EP1210447A2 Adenoviral vectors having nucleic acids encoding immunomodulatory molecules |
| 06/05/2002 | EP1210446A1 Modified ubiquitin regulatory system |
| 06/05/2002 | EP1210445A2 Recombinant microorganisms |
| 06/05/2002 | EP1210444A2 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
| 06/05/2002 | EP1210443A1 High specificity homocysteinases |
| 06/05/2002 | EP1210442A1 ALKALINE PROTEASE VapK SUITABLE FOR LAUNDRY DETERGENT, vapk GENE, RECOMBINANT EXPRESSION VECTOR, AND TRANSFORMED MICROORGANISMS |
| 06/05/2002 | EP1210441A2 Variants of the gamma chain of ampk, dna sequences encoding the same, and uses thereof |
| 06/05/2002 | EP1210440A1 Taq dna polymerases having an amino acid substitution at e681 and homologs thereof exhibiting improved salt tolerance |
| 06/05/2002 | EP1210439A1 Coxsackie virus-derived vector system for gene transfer |
| 06/05/2002 | EP1210438A2 Ehrlichia canis genes and vaccines |
| 06/05/2002 | EP1210437A2 Dihydroorotase extracted from plants |
| 06/05/2002 | EP1210436A2 Male sterile plants |
| 06/05/2002 | EP1210435A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 06/05/2002 | EP1210434A2 Mammalian interleukin-12 p40 and interleukin b30. combinations thereof. antibodies. uses in pharmaceutical compositions |
| 06/05/2002 | EP1210433A2 Methods and compositions of a novel serine protease inhibitor |
| 06/05/2002 | EP1210432A2 i IN VIVO /i TREATMENT OF JOINT DISEASE USING INTERLEUKIN-1 RECEPTOR ANTAGONISTS |
| 06/05/2002 | EP1210431A1 Hepatocyte nuclear factor 4-gamma: hnf4-gamma. |
| 06/05/2002 | EP1210430A2 Muc-1 derived peptides |
| 06/05/2002 | EP1210429A2 Apoptosis proteins |
| 06/05/2002 | EP1210428A1 Pd-1, a receptor for b7-4, and uses therefor |
| 06/05/2002 | EP1210426A2 Polymorphisms in a klotho gene |
| 06/05/2002 | EP1210425A2 Baff receptor (bcma), an immunoregulatory agent |
| 06/05/2002 | EP1210424A1 Novel b7-4 molecules and uses therefor |
| 06/05/2002 | EP1210423A1 Novel abc transporter and uses thereof |
| 06/05/2002 | EP1210422A2 Human abc2 transporter and uses thereof |
| 06/05/2002 | EP1210421A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 06/05/2002 | EP1210420A1 Cd154 ligand, and recombinant cells expressing it |
| 06/05/2002 | EP1210419A2 Human transmembrane proteins |
| 06/05/2002 | EP1210418A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/05/2002 | EP1210417A2 Plant sterol acyltransferases |
| 06/05/2002 | EP1210415A2 Subtilisin protease variants having amino acid substitutions in defined epitope regions |
| 06/05/2002 | EP1210414A1 Alkaline xyloglucanase from malbranchea |
| 06/05/2002 | EP1210413A1 Phytase enzymes, nucleic acids encoding phytase enzymes and vectors and host cells incorporating same |
| 06/05/2002 | EP1210412A1 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 2 promoter and terminator |
| 06/05/2002 | EP1210411A1 Compositions and methods for improved cell culture |
| 06/05/2002 | EP1210408A2 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 06/05/2002 | EP1210405A2 Cardiomyocytes with enhanced proliferative potential, and methods for preparing and using same |
| 06/05/2002 | EP1210374A1 Human monoclonal antibodies to prostate specific membrane antigen |
| 06/05/2002 | EP1210372A2 Human monoclonal antibodies to her2/neu |
| 06/05/2002 | EP1210370A1 Human tumor necrosis factor receptor tr16 |
| 06/05/2002 | EP1210369A1 Monomeric analogues of human insulin |
| 06/05/2002 | EP1210367A1 Sequence derived from a human mammary gland cdna library |
| 06/05/2002 | EP1210366A1 Homologs of a pneumococcal protein and fragments for vaccines |
| 06/05/2002 | EP1210365A2 Methods and compositions for restoring antibiotic susceptibility in glycopeptide-resistant enterococcus |
| 06/05/2002 | EP1210364A1 Vaccine antigens of moraxella |
| 06/05/2002 | EP1210362A2 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses |
| 06/05/2002 | EP1210357A1 OLIGONUCLEOTIDE N3'$m(7)P5' THIOPHOSPHORAMIDATES: THEIR SYNTHESIS AND USE |
| 06/05/2002 | EP1210123A1 Single-stranded oligodeoxynucleotide mutational vectors |
| 06/05/2002 | EP1210122A1 Gene expression with covalently modified polynucleotides |
| 06/05/2002 | EP1210120A1 Nerve cell growth modulators (amphibodies) |